SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Google

WWW Englemed
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
Elite football players 'more likely to develop dementia'
Fri March 17th - Elite male footballers are more likely to develop dementia than the general population, according to a Swedish study published today. More
RECENT COMMENTS
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote:
https://epidemicj17.imascientist.org.uk/2017/06/21... on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
OUR CLIENTS
THIS WEEK'S STORIES
Pharmaceuticals

Pharmaceuticals

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68

06/03/2019 - Warnings on HIV stem cell treatment prospects
Experts have offered caution about hopes of a "cure" for HIV after it was announced that a second patient has achieved full remission after stem cell therapy. More

28/02/2019 - GPs face new antibiotics pressure
Pensioners with urinary tract infections should get rapid antibiotic treatment to reduce risk of sepsis, researchers say today. More

27/02/2019 - Rise in research on rare cancers
Less-common types of cancer are increasingly being studied in research trials, experts have reported. More

13/02/2019 - Early lung cancer test created
A new test could help early diagnosis of lung cancer by measuring levels of DNA in the blood, British researchers have reported. More

07/02/2019 - Heart protection from psoriasis drugs
Treating patients for severe psoriasis also helps reduce their cardiovascular disease risk, researchers have reported. More

01/02/2019 - Statins reduce cardiovascular disease risk in older people - review
Patients over the age of 75 benefit from taking statins to reduce their risk of developing cardiovascular disease, according to an analysis published today. More

23/01/2019 - New doubts over aspirin and cardiovascular disease prevention
The risks from taking aspirin to prevent cardiovascular incidents may outweight the benefits for healthy patients, according to a new systematic review. More

17/01/2019 - Macrophage link to hypertension
Macrophages in the immune system may have a key role in hypertension, according to a project in Edinburgh, UK. More

15/01/2019 - Combination therapy converts cancer cells into fat cells
Scientists have found a drug combination that can turn breast cancer cells into fat cells, it has been announced. More

10/01/2019 - HRT tablets highest VTE risk
Women who take hormone replacement therapy in tablet form may face an increased risk of venous thromboembolism, according to a large UK study published today. More

02/01/2019 - Neoadjuvant treatment complication studied
A recent study has identified a new link between chemotherapy for breast cancer and the spread of the disease. More

27/12/2018 - Hope for new lung cancer therapy
UK researchers are investigating the use of drugs commonly used for breast cancer to treat drug-resistant lung cancer. More

19/12/2018 - Exercise may be best medicine for hypertension
Exercise interventions may be as effective as most medication for hypertension, researchers say today. More

13/12/2018 - Pregnancy pain relief guidance published
Women who need pain relief during pregnancy and while breast-feeding should rely on paracetamol so far as possible, new guidance says today. More

10/12/2018 - Statin adherence and dose important for high risk patients
Patients at high risk from cardiovascular disease should be prescribed high doses of statins and adherence monitored closely, according to a new observational analysis. More

03/12/2018 - Women resist breast cancer prevention drug
Women identified as being at high risk of breast cancer are strongly resistant to taking preventative treatments, according to an analysis published today. More

27/11/2018 - Ebola trial launched
The first randomised controlled trial of a multi-drug treatment for Ebola has begun in Africa, it has been announced. More

21/11/2018 - Vitamin B12 testing in type-2 diabetes
Regular checking of the vitamin B12 levels of patients with type 2 diabetes taking metformin can help prevent irreversible nerve damage, a conference will hear today. More

15/11/2018 - Drug combination for neuroblastoma?
A new drug combination has shown “highly significant” results in laboratory tests on neuroblastoma, a European conference will hear today. More

14/11/2018 - HER2 cancers respond well to new drug
People with cancers of the oesophagus, stomach and colon have experienced positive results from a new anti-HER2 drug, a European conference is being told today. More

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68

Printer friendly page Printer friendly page

CATEGORIES